The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni.

Printer-friendly version
TitleThe cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni.
Publication TypeJournal Article
AuthorsNascimento GL, Pegado HM, Domingues ALC, de Ximenes RAA, Itria A, Cruz LN, de Oliveira MRF
Abbrev. JournalMem. Inst. Oswaldo Cruz
JournalMemorias do Instituto Oswaldo Cruz
Year of Publication2019
Publication Languageeng
KeywordsBrazil, Cost of Illness, Costs, economic burden, Neglected tropical diseases (NTDs), Schistosomiasis

BACKGROUND: Schistosomiasis mansoni is a poverty-related parasitic infection that has a variety of clinical manifestations. We consider the disability and deaths caused by schistosomiasis unacceptable for a tool-ready disease. Its condition in Brazil warrants an analysis that will enable better understanding of the local health losses and contribute to the complex decision-making process.

OBJECTIVE: This study estimates the cost of schistosomiasis in Brazil in 2015.

METHODS: We conducted a cost of illness study of schistosomiasis mansoni in Brazil in 2015 based on a prevalence approach and from a societal perspective. The study included 26,499 schistosomiasis carriers, 397 hepatosplenic cases, 48 cases with the neurological form, 284 hospitalisations, and 11,368.26 years of life lost (YLL) of which 5,187 years are attributable to economically active age groups.

RESULTS: The total cost of schistosomiasis mansoni in Brazil was estimated to be US$ 41,7million in 2015 with 94.61% of this being indirect costs.

CONCLUSIONS: The economic burden of schistosomiasis mansoni in Brazil is high and results in the loss of productivity. Its persistence in Brazil is a challenge to public health and requires inter-sectorial interventions in areas such as indoor water supply, basic sanitation, and education.

PubMed URL

Link to full text